⌘K
Loading ticker…
ProShares Ultra NASDAQ Biotechnology · Other
3m RS is unavailable, Market Stance is 49.9
As of 2026-08-21, ProShares Ultra NASDAQ Biotechnology (BIB) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 49.9 (Neutral). Sector: Other. Average daily range 3.2%, relative volume 1.24×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
| # | Holding | Weight | Value |
|---|---|---|---|
| 1 | IQMM | 6.80% | $5M |
| 2 | GILD | 4.66% | $3M |
| 3 | VRTX | 4.65% | $3M |
| 4 | AMGN | 4.48% | $3M |
| 5 | REGN | 3.21% | $2M |
| 6 | ALNY | 2.01% | $1M |
| 7 | RVMD | 1.57% | $1M |
| 8 | BIIB | 1.44% | $1M |
| 9 | ILMN | 1.25% | $921K |
| 10 | UTHR | 1.22% | $902K |
| 11 | Royalty Pharma plc | 1.20% | $883K |
| 12 | ARGX | 1.19% | $878K |
| 13 | INSM | 1.16% | $852K |
| 14 | INCY | 0.97% | $712K |
| 15 | VTRS | 0.94% | $692K |
| 16 | MRNA | 0.94% | $689K |
| 17 | GH | 0.85% | $629K |
| 18 | NBIX | 0.80% | $588K |
| 19 | SMMT | 0.68% | $503K |
| 20 | EXEL | 0.66% | $485K |
| 21 | BBIO | 0.64% | $475K |
| 22 | MEDP | 0.64% | $470K |
| 23 | IONS | 0.63% | $467K |
| 24 | AXSM | 0.60% | $443K |
| 25 | MDGL | 0.57% | $421K |
Showing 25 of 234 holdings.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BIB Jan avg: 5.22% median: 5.48% win: 100% σ: 4.11% n: 4 2022-04-12 → 2026-07-31 | BIB Feb avg: -1.80% median: 0.04% win: 50% σ: 8.25% n: 4 2022-04-12 → 2026-07-31 | BIB Mar avg: -4.73% median: -4.00% win: 25% σ: 6.42% n: 4 2022-04-12 → 2026-07-31 | BIB Apr avg: -6.15% median: -1.49% win: 40% σ: 9.43% n: 5 2022-04-12 → 2026-07-31 | BIB May avg: -0.83% median: -3.68% win: 40% σ: 8.24% n: 5 2022-04-12 → 2026-07-31 | BIB Jun avg: 6.24% median: 5.65% win: 80% σ: 7.81% n: 5 2022-04-12 → 2026-07-31 | BIB Jul avg: 5.72% median: 7.92% win: 80% σ: 6.80% n: 5 2022-04-12 → 2026-07-31 | BIB Aug avg: 1.52% median: -0.19% win: 50% σ: 5.53% n: 4 2022-04-12 → 2026-07-31 (current) | BIB Sep avg: -2.96% median: -5.63% win: 25% σ: 7.28% n: 4 2022-04-12 → 2026-07-31 | BIB Oct avg: 4.59% median: 5.82% win: 50% σ: 16.60% n: 4 2022-04-12 → 2026-07-31 | BIB Nov avg: 9.00% median: 10.03% win: 75% σ: 7.50% n: 4 2022-04-12 → 2026-07-31 | BIB Dec avg: -0.18% median: -5.79% win: 25% σ: 17.85% n: 4 2022-04-12 → 2026-07-31 |
Metrics matched 219 tickers across 234 holdings rows (63.0% of fund weight). Metrics as of 2026-08-21; holdings from the filing.
Position changes from the to the N-PORT filing.
| Holding | Before → after | Δ weight |
|---|---|---|
| IQMMProShares GENIUS Money Market ETF | — → 6.80% | — |
| TRAXFirst Tracks Biotherapeutics, Inc. | — → 0.02% | — |
| Holding | Before → after | Δ weight |
|---|---|---|
| RVMDRevolution Medicines, Inc. | 0.99% → 1.57% | +0.57 pp |
| GHGuardant Health, Inc. | 0.61% → 0.85% | +0.24 pp |
| ILMNIllumina, Inc. | 1.03% → 1.25% | +0.22 pp |
| AXSMAxsome Therapeutics, Inc. | 0.42% → 0.60% | +0.19 pp |
| Royalty Pharma plc | 1.01% → 1.20% | +0.19 pp |
+64 more
| Holding | Before → after | Δ weight |
|---|---|---|
| GILDGilead Sciences, Inc. | 6.48% → 4.66% | −1.82 pp |
| AMGNAmgen, Inc. | 6.15% → 4.48% | −1.67 pp |
| VRTXVertex Pharmaceuticals, Inc. | 6.27% → 4.65% | −1.62 pp |
| REGNRegeneron Pharmaceuticals, Inc. | 4.06% → 3.21% | −0.86 pp |
| INSMInsmed, Inc. | 1.60% → 1.16% | −0.45 pp |
+40 more
| Holding | Before → after | Δ weight |
|---|---|---|
| Ascendis Pharma A/S | 0.72% → — | — |
| Arcellx, Inc. | 0.33% → — | — |
| Amicus Therapeutics, Inc. | 0.22% → — | — |
| Terns Pharmaceuticals, Inc. | 0.19% → — | — |
| Apellis Pharmaceuticals, Inc. | 0.13% → — | — |
+4 more
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Holdings of BIB currently on TickerStance stock-RS leaderboards.